| Time |
Title |
Room |
|---|---|---|
| 15.00-17.00 |
Satellite symposium: Management of PNH in the Soliris@ (eculizumab) era - Nordic Perspective. Preregistration |
K7 |
| 17.30-20.15 |
Satellite symposium CLL in the spotlight (+buffet) - see separate program sent out by GSK. Preregistration needed. |
K3/K4 |
| Time |
Title |
Room |
|---|---|---|
| 08.00-19.00 |
Registration |
|
| 08.30-10.30 |
Nordic ALL-meeting - "strategies and results from the ALL2008 protocol" |
K3 |
| 09.00-13.00 |
Nordic Bone Marrow Transplantation group meeting (NBMT) |
K2 |
| 11.15-13.00 |
Symposium: Population-based registries in hematology – what have we learned and how should we proceed? |
Hall B |
| 13.00-14.00 |
Lunch |
|
| 14.00-14.05 |
Welcome |
|
| 14.05-15.30 |
Increasing role of allo-SCT in malignant lymphomas and CLL. Assoc. prof. Hans Hägglund, Stockholm (chair), Assoc. prof.Arne Kolstad, University Hospital, Oslo |
Hall B |
| 15.30-16.00 |
Coffee & Exhibition |
|
| 16.00-17.55 |
Myeloproliferative diseases. Chair person Prof. Gunnar Birgegård, Uppsala |
Hall B |
| 16.00-16.45 |
JAK2 mutations - implications for the pathogenesis and treatment of polycythemia vera. |
Hall B |
| 16.45-17.00 |
Musical interlude |
Hall B |
| 17.00-17.55 |
Myeloproliferative diseases – issues in modern management of ET and MF, Assoc. prof. Mats Merup, London |
Hall B |
| 18.00 |
Welcome reception at UKK |
Floor 6 |
| 19.00-20.30 |
Satellite symposium: Defining new standards in indolent NHL and CLL (+ buffet). Preregistration not required. |
Floor 3 -Hall B |
| Time |
Title |
Room |
|---|---|---|
| 08.15-10.00 |
CLL. Chair person Prof. Eva Kimby, Stockholm |
Hall B |
| 08.15-09.05 |
Chronic lymphocytic leukaemia: Prognostic factors and patogenesis. Prof. Richard Rosenqvist-Brandell, Uppsala |
Hall B |
| 09.10-10.00 |
CLL- controversies: Role of antibodies in first and second line treatment? |
Hall B |
| 10.00-10.30 |
Coffee & Exhibition |
|
| 10.30-11.30 |
Acute lymphoblastic leukaemia: Paradigm shift and new concepts in treating ”younger” patients. Prof. Kjell Schmiegelow, Denmark |
Hall B |
| 11.30-12.30 |
Symposium: How to inform patients in the transition to palliative care. Chair person Gunnar Birgegård. Dr Anna Milberg, Norrköping |
Hall B |
| 12.30-13.30 |
Lunch |
| Time |
Title |
Room |
|---|---|---|
| 13.30-15.15 |
Thromboembolism and cancer. Chair person MD PhD Gerd Lärfars, Stockholm |
Hall B |
| 13.30-14.15 |
Thromboembolic complications in cancer patients. Assoc. Prof Margareta Holmström, Stockholm |
Hall B |
| 14.15-15.15 |
New drugs in preventing and treating thrombosis. |
Hall B |
| 15.15-15.45 |
Coffee & Exhibition |
|
| 15.45-17.30 |
Multiple myeloma – state of the art and controversies. ChAssoc. Prof Martin Hjorth, Lidköping (chair). Prof. Peter Gimsing, Copenhagen |
Hall B |
| 17.30-18.00 |
Annual meeting Nordic Society of Hematology. |
Hall B |
| 19.00 |
Conference dinner at Östgöta nation with entertainment, including renowned speaker |
| Time |
Title |
Room |
|---|---|---|
| 08.30-10.00 |
Acute myeloid leukaemia. Chair person: Prof. Eva Hellström-Lindberg, Stockholm |
Hall B |
| 08.30-09.20 |
Genetic diagnostics in acute leukaemia - now and future. Prof. Claudia Haferlach, Munich |
Hall B |
| 09.20-10.00 |
New drugs in the treatment of AML. |
Hall B |
| 10.00-10.30 |
Coffee & Exhibition |
|
| 10.30-12.00 |
Debate: Better for the patient, more expensive for the clinic = increasing dilemma for the doctor: How to evaluate the cost-effectiveness of the novel haematologic drugs. Chair person Prof. Jan Westin, Göteborg.
|
Hall B |
| 12.00-13.00 |
Lunch |
|
| 13.00-14.50 |
Clinical frontlines in ITP and CML. Chair persons: assoc. prof. Martin Höglund, Uppsala and prof. Johan Richter, Lund |
Hall B |
| 13.00-14.00 |
TKIs in very-good-responder-CML – stop or non-stop? Prof Kimmo Porkka, Helsinki |
Hall B |
| 14.00-14.50 |
Autoimmune thrombocytopenia – choice of second line treatment and role of TPO-agonists. Prof. Hans Wadenvik, Göteborg |
Hall B |
| 14.50 |
Closing words |
| Time |
Title |
Room |
|
|---|---|---|---|
| 08.00-19.00 |
Registration |
||
| 10.00-11.00 |
Annual meeting of HEMSIS (Swedish Hematology Nurses Society) |
Hall C |
|
| 11.15-13.00 |
see - main program! |
Hall B |
|
| 13.00-14.00 |
Lunch |
||
| 14.00-14.05 |
Welcome |
Hall C |
|
| 14.05-15.30 |
Stem cell transplantation and sexuality Chair person: nurse Ann-Carin Svanberg |
Hall C |
|
| 14.05-14.50 |
Gynelogical complications after stem cell transplantation. |
Hall C |
|
| 14.50-15.30 |
The impact of SCT on sexual life |
Hall C |
|
| 15.30-16.00 |
Coffee & Exhibition |
||
| 16.00-17.45 |
Nurse – patient relation Chair person: nurse Ann-Carin Svanberg |
Hall C |
|
| 16.00-16.50 |
Ethical problems, attitudes |
Hall C |
|
| 17.00-17.45 |
”The Insider and Outsider Perspective – clinical importance of agreement between patients and nurses in cancer care” PhD Gunilla Mårtensson, Uppsala |
Hall C |
|
| 18.00 |
Welcome reception at UKK |
Floor 6 |
| Time |
Title |
Room |
|---|---|---|
| 08.15-09.15 |
To talk to patients about difficult issues. |
Hall C |
| 09.15-11.30 |
Management of infections in immunodeficient patients. Chair person Ann-Carin Svanberg |
Hall C |
| 09.15-10.15 |
Multiresistant bacteria – an emerging problem in hematological patients, Dr Birgitta Lytsy, Uppsala |
Hall C |
| 10.15-10.45 |
Coffee & Exhibition |
|
| 10.45-11.30 |
Antibiotic treatment of patients with febrile neutropenia Dr Honar Cherif, Uppsala |
Hall C |
| 11.30-12.30 |
Symposium: How to inform patients in the transition to palliative care. |
Hall B |
| 12.30-13.30 |
Lunch |
|
| 13.30-17.30 |
Nurses are very welcome to participate in the general sessions on Thursday afternoon and on Friday 23/4 |
Hall B |
| 19.00 |
Conference dinner at Östgöta nation with entertainment, including renowned speaker |
41st
Nordic Hematology Spring Meeting
21-23 April 2010, Uppsala Konsert & Kongress
Invitation and program